trending Market Intelligence /marketintelligence/en/news-insights/trending/M9CdNw7QfDjzF8qnuIfBWA2 content esgSubNav
In This List

Agile Therapeutics prices $20M common stock offering

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Agile Therapeutics prices $20M common stock offering

Agile Therapeutics Inc. priced an underwritten public offering of 5,333,334 common shares at $3.75 apiece for gross proceeds of about $20 million.

The company also granted underwriters a 30-day option to buy up to an additional 800,000 of the shares offered.

William Blair, RBC Capital Markets and Cantor Fitzgerald & Co. are acting as joint book-running managers for the offering. Janney Montgomery Scott is also acting as lead manager, and Noble Capital Markets is acting as a co-manager.

The offering is expected to close by Aug. 8.